Caplight Directory>Companies>Mitotech-preview>Mitotechpharma


Mitotech

Mitotech

Private
LuxembourgHealthcare & Life Scienceshttps://mitotechpharma.com/

Last Round

Strategic

Jul 16, 2018

Total Funding Raised

$17M

Company Overview

Mitotech is a biotechnology company that develops novel drugs for the treatment of age-related disorders based on mitochondria-targeting cardiolipin peroxidation inhibitors.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Revenue Share, Hardware Sales, Government Contracts

AI Layer

Non-AI

Keywords

mitochondrial dysfunctionSkQ1dry eye diseaseophthalmic drug developmentlongevity biotechVisomitinclinical-stage biotechsmall molecule drugoxidative stresseye dropsdrug licensingcardiolipin peroxidationneurodegenerative diseaseLeber's Hereditary Optic NeuropathyLHON

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Mitotech Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Mitotech Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
StrategicJul 16, 2018
VC RoundFeb 24, 2010
View all Funding Rounds

Mitotech Investors

Notable investors and investment history

InvestorRounds
Essex Bio-TechnologyStrategic
RusnanoVC Round
View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 8, 2025

    Monthly visitors grew 89% MoM.

  • May 1, 2025

    Monthly visitors increased 170% MoM.

View all signals

Mitotech Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Mitotech Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Mitotech's valuation, stock price, and market status.

Firmographic Details

HeadquartersLuxembourg
Employee Range7
Year Founded2010
Last FundingJul 16, 2018

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.